How much revenue did Almirall generate this year?
Almirall has achieved a revenue of 984.71 M EUR this year.
Almirall Revenue 2024
Almirall Revenue
984.71 M EUR
Ticker
ALM.MC
ISIN
ES0157097017
WKN
A0MU8Y
In 2024, Almirall's sales reached 984.71 M EUR, a 10.08% difference from the 894.52 M EUR sales recorded in the previous year.
The Almirall Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 1.46 | 46,68 |
| 2027e | 1.32 | 51,67 |
| 2026e | 1.22 | 56,13 |
| 2025e | 1.1 | 62,12 |
| 2024e | 0.98 | 69,26 |
| 2023 | 0.89 | 76,25 |
| 2022 | 0.86 | 78,94 |
| 2021 | 0.83 | 79,11 |
| 2020 | 0.81 | 78,64 |
| 2019 | 0.86 | 77,50 |
| 2018 | 0.76 | 78,52 |
| 2017 | 0.64 | 72,94 |
| 2016 | 0.76 | 78,70 |
| 2015 | 0.68 | 77,99 |
| 2014 | 0.79 | 78,20 |
| 2013 | 0.69 | 74,74 |
| 2012 | 0.68 | 69,51 |
| 2011 | 0.87 | 73,27 |
| 2010 | 1 | 72,68 |
| 2009 | 1.03 | 72,03 |
| 2008 | 1.06 | 73,48 |
| 2007 | 0.92 | 71,66 |
| 2006 | 0.85 | 71,82 |
| 2005 | 0.8 | 71,64 |
| 2004 | 0.75 | 72,14 |
Almirall Revenue, EBIT, Net Income ES0157097017 · A0MU8Y
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Almirall, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Almirall from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Almirall’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Almirall. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Almirall’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Almirall’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Almirall’s growth potential.
Almirall Revenue, EBIT and net profit per share
| Date | Almirall Revenue | Almirall EBIT | Almirall Net Income |
|---|---|---|---|
| 2028e | 1.46 B undefined | 176.13 M undefined | 188.01 M undefined |
| 2027e | 1.32 B undefined | 141.26 M undefined | 151.5 M undefined |
| 2026e | 1.22 B undefined | 155.06 M undefined | 142.01 M undefined |
| 2025e | 1.1 B undefined | 109.46 M undefined | 103.02 M undefined |
| 2024e | 984.71 M undefined | 65.08 M undefined | 45.19 M undefined |
| 2023 | 894.52 M undefined | 40.42 M undefined | -38.47 M undefined |
| 2022 | 863.25 M undefined | 54.62 M undefined | 4.28 M undefined |
| 2021 | 827.2 M undefined | 102.39 M undefined | -40.86 M undefined |
| 2020 | 807.43 M undefined | 103.06 M undefined | 74.28 M undefined |
| 2019 | 855.34 M undefined | 107.94 M undefined | 105.91 M undefined |
| 2018 | 756.93 M undefined | 56.56 M undefined | 77.67 M undefined |
| 2017 | 639.38 M undefined | -54.58 M undefined | -303.96 M undefined |
| 2016 | 764.36 M undefined | 62.23 M undefined | 75.48 M undefined |
| 2015 | 684.99 M undefined | 83.14 M undefined | 131.83 M undefined |
| 2014 | 786.4 M undefined | -2.6 M undefined | 448.4 M undefined |
| 2013 | 692.9 M undefined | 6.3 M undefined | -33.7 M undefined |
| 2012 | 682.9 M undefined | 55.3 M undefined | 76.3 M undefined |
| 2011 | 873.1 M undefined | 96.9 M undefined | 84.2 M undefined |
| 2010 | 1 B undefined | 154.4 M undefined | 118.6 M undefined |
| 2009 | 1.03 B undefined | 179.1 M undefined | 151.5 M undefined |
| 2008 | 1.06 B undefined | 165.8 M undefined | 136.1 M undefined |
| 2007 | 917.4 M undefined | 134.1 M undefined | 131.2 M undefined |
| 2006 | 854.1 M undefined | 115.4 M undefined | 147.3 M undefined |
| 2005 | 798.4 M undefined | 128.4 M undefined | 117.7 M undefined |
| 2004 | 745.2 M undefined | 108.7 M undefined | 92.6 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 745.2 M EUR | 108.7 M EUR | 92.6 M EUR |
| 2005 | 798.4 M EUR | 128.4 M EUR | 117.7 M EUR |
| 2006 | 854.1 M EUR | 115.4 M EUR | 147.3 M EUR |
| 2007 | 917.4 M EUR | 134.1 M EUR | 131.2 M EUR |
| 2008 | 1.06 B EUR | 165.8 M EUR | 136.1 M EUR |
| 2009 | 1.03 B EUR | 179.1 M EUR | 151.5 M EUR |
| 2010 | 1 B EUR | 154.4 M EUR | 118.6 M EUR |
| 2011 | 873.1 M EUR | 96.9 M EUR | 84.2 M EUR |
| 2012 | 682.9 M EUR | 55.3 M EUR | 76.3 M EUR |
| 2013 | 692.9 M EUR | 6.3 M EUR | -33.7 M EUR |
| 2014 | 786.4 M EUR | -2.6 M EUR | 448.4 M EUR |
| 2015 | 684.99 M EUR | 83.14 M EUR | 131.83 M EUR |
| 2016 | 764.36 M EUR | 62.23 M EUR | 75.48 M EUR |
| 2017 | 639.38 M EUR | -54.58 M EUR | -303.96 M EUR |
| 2018 | 756.93 M EUR | 56.56 M EUR | 77.67 M EUR |
| 2019 | 855.34 M EUR | 107.94 M EUR | 105.91 M EUR |
| 2020 | 807.43 M EUR | 103.06 M EUR | 74.28 M EUR |
| 2021 | 827.2 M EUR | 102.39 M EUR | -40.86 M EUR |
| 2022 | 863.25 M EUR | 54.62 M EUR | 4.28 M EUR |
| 2023 | 894.52 M EUR | 40.42 M EUR | -38.47 M EUR |
| 2024e | 984.71 M EUR | 65.08 M EUR | 45.19 M EUR |
| 2025e | 1.1 B EUR | 109.46 M EUR | 103.02 M EUR |
| 2026e | 1.22 B EUR | 155.06 M EUR | 142.01 M EUR |
| 2027e | 1.32 B EUR | 141.26 M EUR | 151.5 M EUR |
| 2028e | 1.46 B EUR | 176.13 M EUR | 188.01 M EUR |
Almirall stock margins ES0157097017 · A0MU8Y
The Almirall margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Almirall. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Almirall.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Almirall's sales revenue. A higher gross margin percentage indicates that the Almirall retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Almirall's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Almirall's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Almirall's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Almirall. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Almirall's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Almirall Margin History
| Almirall Gross margin | Almirall Profit margin | Almirall EBIT margin | Almirall Profit margin |
|---|---|---|---|
| 2028e | 76.25 % | 12.06 % | 12.87 % |
| 2027e | 76.25 % | 10.7 % | 11.48 % |
| 2026e | 76.25 % | 12.76 % | 11.69 % |
| 2025e | 76.25 % | 9.97 % | 9.38 % |
| 2024e | 76.25 % | 6.61 % | 4.59 % |
| 2023 | 76.25 % | 4.52 % | -4.3 % |
| 2022 | 78.94 % | 6.33 % | 0.5 % |
| 2021 | 79.11 % | 12.38 % | -4.94 % |
| 2020 | 78.64 % | 12.76 % | 9.2 % |
| 2019 | 77.5 % | 12.62 % | 12.38 % |
| 2018 | 78.52 % | 7.47 % | 10.26 % |
| 2017 | 72.94 % | -8.54 % | -47.54 % |
| 2016 | 78.7 % | 8.14 % | 9.87 % |
| 2015 | 77.99 % | 12.14 % | 19.25 % |
| 2014 | 78.2 % | -0.33 % | 57.02 % |
| 2013 | 74.74 % | 0.91 % | -4.86 % |
| 2012 | 69.51 % | 8.1 % | 11.17 % |
| 2011 | 73.27 % | 11.1 % | 9.64 % |
| 2010 | 72.68 % | 15.41 % | 11.84 % |
| 2009 | 72.03 % | 17.33 % | 14.66 % |
| 2008 | 73.48 % | 15.7 % | 12.89 % |
| 2007 | 71.66 % | 14.62 % | 14.3 % |
| 2006 | 71.82 % | 13.51 % | 17.25 % |
| 2005 | 71.64 % | 16.08 % | 14.74 % |
| 2004 | 72.14 % | 14.59 % | 12.43 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 72.14 % | 14.59 % | 12.43 % |
| 2005 | 71.64 % | 16.08 % | 14.74 % |
| 2006 | 71.82 % | 13.51 % | 17.25 % |
| 2007 | 71.66 % | 14.62 % | 14.3 % |
| 2008 | 73.48 % | 15.7 % | 12.89 % |
| 2009 | 72.03 % | 17.33 % | 14.66 % |
| 2010 | 72.68 % | 15.41 % | 11.84 % |
| 2011 | 73.27 % | 11.1 % | 9.64 % |
| 2012 | 69.51 % | 8.1 % | 11.17 % |
| 2013 | 74.74 % | 0.91 % | -4.86 % |
| 2014 | 78.2 % | -0.33 % | 57.02 % |
| 2015 | 77.99 % | 12.14 % | 19.25 % |
| 2016 | 78.7 % | 8.14 % | 9.87 % |
| 2017 | 72.94 % | -8.54 % | -47.54 % |
| 2018 | 78.52 % | 7.47 % | 10.26 % |
| 2019 | 77.5 % | 12.62 % | 12.38 % |
| 2020 | 78.64 % | 12.76 % | 9.2 % |
| 2021 | 79.11 % | 12.38 % | -4.94 % |
| 2022 | 78.94 % | 6.33 % | 0.5 % |
| 2023 | 76.25 % | 4.52 % | -4.3 % |
| 2024e | 76.25 % | 6.61 % | 4.59 % |
| 2025e | 76.25 % | 9.97 % | 9.38 % |
| 2026e | 76.25 % | 12.76 % | 11.69 % |
| 2027e | 76.25 % | 10.7 % | 11.48 % |
| 2028e | 76.25 % | 12.06 % | 12.87 % |
Almirall Aktienanalyse
What does Almirall do?
The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Almirall's Sales Figures
The sales figures of Almirall originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Almirall’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Almirall's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Almirall’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Almirall stock
How much was the turnover of the company Almirall compared to the previous year?
The revenue of Almirall has increased by 10.08% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Almirall?
The revenue of Almirall is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Almirall measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Almirall so important for investors?
The revenue of Almirall is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Almirall pay?
Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.
What is the dividend yield of Almirall?
The current dividend yield of Almirall is 2.17 %.
When does Almirall pay dividends?
Almirall pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Almirall?
Almirall paid dividends every year for the past 14 years.
What is the dividend of Almirall?
For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 2.14 %.
In which sector is Almirall located?
Almirall is assigned to the 'Health' sector.
Wann musste ich die Aktien von Almirall kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Almirall from 6/12/2024 amounting to 0.184 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
When did Almirall pay the last dividend?
The last dividend was paid out on 6/12/2024.
What was the dividend of Almirall in the year 2023?
In the year 2023, Almirall distributed 0.186 EUR as dividends.
In which currency does Almirall pay out the dividend?
The dividends of Almirall are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Almirall
Our stock analysis for Almirall Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Almirall Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
